P. Kent Hawryluk

Insider Reports History

Location
Livonia, MI
Signature
/s/ Richard Bartram, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by P. Kent Hawryluk:

Company Role Class Num Shares Value Price $ Report Date Ownership
MBX Biosciences, Inc. President & CEO, Director Common Stock 468,277 $18,979,266 $40.53 26 Feb 2026 By Trust
MBX Biosciences, Inc. President & CEO, Director Common Stock 728,274 $11,652,384 $16.00 26 Feb 2026 Direct
MBX Biosciences, Inc. President & CEO, Director Stock option (right to buy) 91,668 26 Feb 2026 Direct

Insider Reports Filed by P. Kent Hawryluk

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MBX MBX Biosciences, Inc. 26 Feb 2026 2 +$460,288 4 President & CEO, Director 27 Feb 2026, 16:07
MBX MBX Biosciences, Inc. 02 Feb 2026 2 $0 4 President & CEO, Director 03 Feb 2026, 16:16
MBX MBX Biosciences, Inc. 24 Oct 2025 2 +$594,292 4 President & CEO, Director 28 Oct 2025, 08:03
MBX MBX Biosciences, Inc. 20 Oct 2025 1 +$272,790 4 President & CEO, Director 21 Oct 2025, 17:43
MBX MBX Biosciences, Inc. 03 Feb 2025 2 +$534,500 4 President & CEO, Director 05 Feb 2025, 16:17
MBX MBX Biosciences, Inc. 16 Sep 2024 7 $0 4 President & CEO, Director 17 Sep 2024, 20:07
MBX MBX Biosciences, Inc. 12 Sep 2024 1 $0 4 President & CEO, Director 13 Sep 2024, 17:06
MBX MBX Biosciences, Inc. 12 Sep 2024 0 $0 3 President & CEO, Director 12 Sep 2024, 19:34